Taking it to the streets. Stockhouse.com: Taking it to the street
urlyretirement’s details
My Bullboard Posts
 
No additional content to display.
 
My Blogs
 
LATEST ENTRIES
8/31/2011 11:47:10 AM  | 267 reads  | 3 comments  | overall quality: 3
SIRONA released news this morning that they have actually developed a cancer vaccine agent. Something the big pharmas have been trying to do for decades. The news came out, and the stock actually dropped. This is a buying opportunity like no other...
8/31/2011 9:53:36 AM  | 318 reads  | overall quality: 1
Wednesday, August 31st, 2011Sirona Biochem Develops Cancer Vaccine Antigen
8/30/2011 12:53:17 AM  | 4215 reads  | overall quality: 3
The shares seem certainly worth buying at .44 on a worst-case basis, to await the possibility of success with scalability. In conclusion, assuming a worst-case scenario at .44, shares of Argex have the potential to be a “Five Bagger” while simulta...
8/29/2011 7:59:13 PM  | 678 reads  | overall quality: 5
The shares seem certainly worth buying at .44 on a worst-case basis, to await the possibility of success with scalability. In conclusion, assuming a worst-case scenario at .44, shares of Argex have the potential to be a “Five Bagger” while simulta...
8/29/2011 7:58:11 PM  | 6204 reads  | overall quality: 1
The shares seem certainly worth buying at .44 on a worst-case basis, to await the possibility of success with scalability. In conclusion, assuming a worst-case scenario at .44, shares of Argex have the potential to be a “Five Bagger” while simulta...
8/29/2011 12:18:41 PM  | 593 reads  | 2 comments  | overall quality: 3
The shares seem certainly worth buying at .44 on a worst-case basis, to await the possibility of success with scalability. In conclusion, assuming a worst-case scenario at .44, shares of Argex have the potential to be a “Five Bagger” while simulta...
8/29/2011 10:24:11 AM  | 5056 reads  | 3 comments  | overall quality: 3
http://visitor.benchmarkemail.com/c/l?u=2D7480&e=E4338&c=1A086&t=1&email=bJZYshHqS7aKl%2F%2FXhHSgNV3HDCnO7K4FRGX.v current price .41short term target $2.00long term target $31.00
8/19/2011 11:54:15 AM  | 511 reads  | overall quality: 2
Zacks Investment Research April 26, 2011 Update
8/19/2011 1:26:27 AM  | 5813 reads  | 2 comments  | overall quality: 2
Zacks Investment Research April 26, 2011 Update
8/18/2011 5:28:34 AM  | 827 reads  | overall quality: 3
Watch videoThey are definitely onto something grand. Apparently, they are about to revolutionize the multi-billion dollar cancer detection industry.By all accounts... I think its true. I think they have done it. Test results are due any day now......
 
 
Discover your inner journalist
 
Submit an article for editorial consideration. Find out more.
 
 
 
 
 
Today's Feature  
 
Pacific North West Capital Corp.
Pacific North West Capital Corp. (TSX: PFN; OTCQX: PAWEF; Frankfurt: P7J) is a mineral exploration company focused on the discovery, exploration and development of PGM and nickel-copper sulphide deposits in geologically prospective regions in North America, particularly Canada. The Company's key asset is its 100% owned River Valley PGM Project in the Sudbury region of northern Ontario. The River Valley Project is one of North America's most advanced primary PGM deposits...